{"id":"clm_B36E746D71D8","entity":"abbvie","predicate":"quarterly_net_income","value":"3,179,000,000 United States dollar","value_json":{"fp":"Q3","fy":2021,"accn":"0001551152-21-000031","form":"10-Q","filed":"2021-11-02","period":"Q3 FY2021","concept":"us-gaap:NetIncomeLoss"},"valid_from":"2021-09-30","valid_to":"2022-03-31","published":"2021-11-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"AbbVie quarterly net income: 3,179,000,000 United States dollar\", as of 2021-09-30 (until 2022-03-31). Claim clm_B36E746D71D8, https://asof.is/claim/clm_B36E746D71D8, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1551152/000155115221000031/0001551152-21-000031-index.htm.","url":"https://asof.is/claim/clm_B36E746D71D8","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_0A98B6612119","supersedes":["clm_8C62E1009F26"],"first_seen_at":"2026-11-08T15:32:59.934139+00:00","updated_at":"2026-11-08T15:33:08.46324+00:00","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1551152/000155115221000031/0001551152-21-000031-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2021","published_at":"2021-11-02T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2021, filed 2021-11-02"},"legend":{"dates":"valid_from: when the claim took effect (a period figure: the day its period closed). published: the earliest day a source on the record published it (a filing's filing date, a post's date; null when no source carries one). recorded: the day AsOf first held it. A figure can take effect weeks before it is published.","citation":"citation: how to cite the row (plain: one sentence with the value, its as-of date, the claim id and URL, the day answered and the primary source; url: the claim page; accessed: the day answered). APA and BibTeX forms are on the claim page.","why_not":{},"checked_by":{"sec-filing":"parsed from the SEC filing"}}}